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Abstract
Studies in rodent models of breast cancer show that exposures to dietary/hormonal factors during the in utero and pubertal periods, when the
mammary gland undergoes extensive modeling and re-modeling, alter susceptibility to carcinogen-induced mammary tumors. Similar findings
have been described in humans: for example, high birthweight increases later risk of developing breast cancer, and dietary intake of soy during
childhood decreases breast cancer risk. It is thought that these prenatal and postnatal dietary modifications induce persistent morphological
changes in the mammary gland that in turn modify breast cancer risk later in life. These morphological changes likely reflect epigenetic
modifications, such as changes in DNA methylation, histones and miRNA expression that then affect gene transcription . In this article we
describe how changes in mammary gland morphology can predict mammary cancer risk in rats. Our protocol specifically describes how to dissect
and remove the rat abdominal mammary gland and how to prepare mammary gland whole mounts. It also describes how to analyze mammary
gland morphology according to three end-points (number of terminal end buds, epithelial elongation and differentiation) and to use the data to
predict risk of developing mammary cancer.
Protocol
1. Removal of the Abdominal Mammary Gland and Preparing a Whole Mount
2. Analysis of Mammary Gland Whole Mount Morphology
Mammary gland whole mounts morphology is analyzed according to the following end-points and the results correlated with mammary cancer
risk.
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1. Euthanize the animal according to the IACUC guidelines. Pin the animal on its back from its legs with needles, or tape the legs onto the
surface board , and wipe the skin wet with ethanol (EtOH). Lift the skin a little bit with forceps and with sharp scissors make a midline incision
into the skin starting between the pair #5 nipples and cut towards the neck . Make an inverted Y incision from the midline towards the hind
legs . If thoracic mammary glands are also to be collected, make also an Y incision from the midline between the pair #2 nipples towards the
front legs.
2. Dissect the skin open with scissors on one side of the inverted Y incision to expose the abdominal #4 mammary gland; the mammary glands
are attached to the skin. Pin the skin with needles onto the surface board , to completely expose the gland. Work one side and gland at the
time.
3. Dissect the mammary gland free from the skin either using sharp scissors and/or a scalpel, starting from the proximal area close to the nipple
and working towards the distal end of the gland towards the spine of the animal . (This can take several minutes, especially in an older rat.)
4. Immediately spread the detached gland onto an appropriately labeled glass slide (use a proper permanent marker pen and/or 'a diamond
pen'), and spread the gland carefully corresponding to its original size and shape in situ . The glass slide must be bigger than the gland. After
spreading the gland onto the slide, let it sit on the table for a while, so that the gland sticks onto the slide, but don't let it dry.
5. Put the slide into a jar containing Carnoy's fixative (75% glacial acetic acid, 25% absolute ethanol=EtOH) , let it get fixed at room temperature
(RT) in the fume hood for 2 days or longer. Slides can also be left in the fixative for a longer period of time.
6. Wash the slides in 70% EtOH for 1 hour at RT.
7. Rinse in distilled water for 30 min at RT.
8. Stain in Carmine Alum stain*) for 2 days or longer (until you see that the lymph nodes have stained through; look at the back side of the
slide).
9. Wash in increasing series of EtOH, 1 hour in each: 70% -> 95% -> 100% . After the last wash in absolute EtOH put the glands in xylene . Let
sit in the fume hood in RT at least for 2 days. This last step is clearing of the mammary gland meaning delipidation of the mammary fat pad,
and subsequent increase in transparency. The fattier the gland is the longer clearing time is required.
10. Mount with cover-slips using a mounting media, such as Permount . Let the slides dry well (several days) before observing under a stereo
microscope.
*Carmine Alum Stain:
Place 1 g carmine (Sigma C1022) and 2.5 g aluminum potassium sulfate (Sigma A7167) in 500 mL distilled water and boil for 20 min. Adjust
final volume to 500 mL with water. Filter and refrigerate. Solution can be used for several months. Discard when color becomes weak.
1. Mammary gland whole-mount at PND 21 (pre-pubertal age):
• Epithelial growth:
• Distance from the nipple to the end of epithelial tree (in millimeters), measured using a ruler3. Palpation and Mammary Tumor Measurement in Rats and Correlation to Mammary Gland
Morphology
4. Representative Results
Careful dissection of the mammary fat pad and its processing to wholemount will allow assessment of developmental state of the mammary
gland. When each step is done correctly, the whole mammary epithelial tree is clearly visible within the fat pad, and this allows easy determination
of the number of TEBs and calculation of the density of alveolar buds and lobules. Missteps in preparing wholemounts may include failure to
dissect the whole fat pad, insufficient fixing, and inadequate clearing.
Assessment of mammary gland morphology will provide information about the number of structures present that can give rise to mammary
tumors (TEBs), degree of differentiation of the epithelial structures (alveolar buds and lobules), and measure of growth (ductal elongation). It is
important to separate TEBs to terminal ends; the latter are located at the distal end of the epithelium, similarly to TEBs, but they are smaller than
TEBs and do not give rise to malignant tumors. Terminal ends are also seen within the epithelial tree.
Figure 1: Representative result of well prepared mammary gland whole mount. All components of the gland have been properly dissected
and carmine staining is optimal.
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• Potential for malignant transformation:
• Number of TEBs (terminal end buds), counted under a light microscope . TEBs are the largest bulbous structures located only at
the distal end of the mammary epithelial tree
• Differentiation:
• AB1 (alveolar bud) score (0-5). Alveolar buds are spread across the epithelium.
• AB2 score (0-5)
Wholes mounts are scored under a light microscope. The score values from AB1 and AB2 are added for a final differentiation score.
2. Mammary gland whole-mount collected at PND 50 (post-pubertal age) :
• Epithelial growth:
• Distance from the lymph node to the end of epithelial tree (in millimeters), measured using a ruler.
• Distance from the tip of the epithelial tree to the end of fat pad, measured using a ruler.
• Potential for malignant transformation:
• Number of TEBs, counted under a light microscope
• Differentiation:
• AB1 score (0-5)
• AB2 score (0-5)
• Lobules score (0-5)
Wholes mounts are scored under a light microscope. Differentiation will be assesses in two ways. First, the score values from AB1, AB2 and
lobules are added for a final differentiation score. In addition, the ratio between lobules score and AB1+AB2 score will be calculated. ABs
differentiate to lobules, and the higher the ratio between lobules and ABs, the more differentiated the gland is.
1. To begin this procedure, hold the rat by grasping the whole body with the palm over the back, with forefinger behind the head and the thumb
and second finger under the opposite axilla. Turn the rat so it is lying on its posterior, and palpate to detect any mammary tumors; palpable
tumors should feel like a "lump".
2. Next use a caliper to measure the width, length, and height of the tumor. Calculate the tumor volume using the ellipsoid formula, Volume
=1/6πabc, where 'a'= width, 'b' = length, and 'c' = height.
3. Manually record the location and size of the tumor in a notebook on a weekly basis. This data will be transferred to a spreadsheet later.Figure 2: Representative result of a poorly prepared mammary gland whole mount. The gland has been properly dissected (the distal
portion of the gland is missing), has not been properly stretched and delipidation has not completely occurred.
Discussion
Assessment of mammary gland morphological end-points and the growth of the epithelial tree can be used to predict whether early life dietary
manipulations, or other manipulations which alter in utero or prepubertal hormonal environment, modify later mammary cancer risk. Since breast
cancer in humans is initiated in mammary structures (terminal ductal lobular units, TDLUs) similar to TEBs in rats, this technique can be used to
determine the potential of early life exposures to affect breast cancer risk. Further, in women high mammographic density increases the risk of
breast cancer by 4-6 fold, and assessment of the growth of mammary epithelial tree can be used to identify factors which determine
mammographic density and factors which reduce this density. To obtain this information, mammary gland should be fully dissected, properly
stretched on a glass slide so that all its components can be visualized under a microscope. In addition, proper carmine staining and delipidation in
xylene will provide whole mounts that are suitable for mammary cancer risk assessment.
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